Investing.com
Atossa and Weill Cornell expand breast cancer drug research By Investing.com
Atossa Therapeutics, Inc. (NASDAQ:ATOS), a biopharmaceutical company, announced today an expanded research agreement with Weill Cornell Medicine to further study the combination of antibody-drug ...
4 days ago